☰

Muhammad Latif - Publications

Affiliations: 
2011-2012 Bioorganic Science Division Korea Research Institute of Chemical Technology, Republic of Korea 
Tree Info Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yaseen M, Rashid MA, Iqbal MA, Farooq Z, Idrees M, Qayyum MA, Intisar A, Mahmood MHR, Khan I, Latif M. Synthesis, photoinduced, amination and topological indices of novel porphyrin dyads Journal of Porphyrins and Phthalocyanines. 24: 1054-1065. DOI: 10.1142/S1088424620500200  0.362
2019 Nazir Y, Saeed A, Rafiq M, Afzal S, Ali A, Latif M, Zuegg J, Hussein WM, Fercher C, Barnard RT, Cooper MA, Blaskovich MAT, Ashraf Z, Ziora ZM. Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies. Bioorganic & Medicinal Chemistry Letters. 126722. PMID 31732410 DOI: 10.1016/J.Bmcl.2019.126722  0.352
2019 Iqbal Z, Iqbal A, Ashraf Z, Latif M, Hassan M, Nadeem H. Synthesis and docking studies of N-(5-(alkylthio)-1,3,4-oxadiazol-2-yl)methyl)benzamide analogues as potential alkaline phosphatase inhibitors. Drug Development Research. PMID 31032540 DOI: 10.1002/Ddr.21542  0.369
2018 Mah S, Jang J, Song D, Shin Y, Latif M, Jung Y, Hong S. Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase. Organic & Biomolecular Chemistry. PMID 30534706 DOI: 10.1039/C8Ob02874E  0.4
2018 Latif M, Ashraf Z, Basit S, Ghaffar A, Zafar MS, Saeed A, Meo SA. Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments Rsc Advances. 8: 16470-16493. DOI: 10.1039/C8Ra01934G  0.362
2017 Abbas Q, Ashraf Z, Hassan M, Nadeem H, Latif M, Afzal S, Seo SY. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies. Drug Design, Development and Therapy. 11: 2029-2046. PMID 28740364 DOI: 10.2147/Dddt.S137550  0.344
2017 Basit S, Ashraf Z, Lee K, Latif M. First macrocyclic 3(rd)-generation ALK inhibitor for treatment of ALK/ROS1 cancer: Clinical and designing strategy update of lorlatinib. European Journal of Medicinal Chemistry. 134: 348-356. PMID 28431340 DOI: 10.1016/J.Ejmech.2017.04.032  0.391
2016 Choe H, Pham TT, Lee JY, Latif M, Park H, Kang YK, Lee J. Remote Stereoinductive Intramolecular Nitrile Oxide Cycloaddition: Asymmetric Total Synthesis and Structure Revision of (-)-11beta-Hydroxycurvularin. The Journal of Organic Chemistry. PMID 26894643 DOI: 10.1021/Acs.Joc.5B02760  0.698
2015 Latif M, Yun JI, Seshadri K, Kim HR, Park CH, Park H, Kim H, Lee J. Stereoselective construction of 2,6-cis-disubstituted tetrahydropyrans via intramolecular amide enolate alkylation: total synthesis of (-)-centrolobine. The Journal of Organic Chemistry. 80: 3315-20. PMID 25723100 DOI: 10.1021/Acs.Joc.5B00046  0.681
2015 Saeed A, Ejaz SA, Khurshid A, Hassan S, Al-Rashida M, Latif M, Lecka J, Sévigny J, Iqbal J. Synthesis, characterization and biological evaluation of N-(2,3-dimethyl-5-oxo-1-phenyl-2,5-dihydro-1H-pyrazol-4-yl)benzamides Rsc Advances. 5: 86428-86439. DOI: 10.1039/C5Ra17568B  0.325
2015 Latif M, Park S, Ali I, Choe H, Chae CH, Park CH, Kim HR, Yun CS, Lee K. Design, synthesis, and evaluation of 2-anilino-4-(3,5-dicarboxamidespiperidine)-pyrimidines as anaplastic lymphoma kinase inhibitors Bulletin of the Korean Chemical Society. 36: 2397-2400. DOI: 10.1002/Bkcs.10454  0.675
2015 Moon SH, Latif M, Qasim M, Choi SW, Lee JY, Byun BJ, Saeed A, Kim SH. Synthesis, characterization, and biological evaluation of oxadiazole derivatives bearing 5-phenyl-tetrazole as osteoclast differentiation inhibitors Bulletin of the Korean Chemical Society. 36: 2247-2253. DOI: 10.1002/Bkcs.10436  0.392
2015 Latif M, Byun BJ, Lee K. Synthesis of 4-(3,4-dicarboxamido-1H-pyrrole)pyrimidines as anaplastic lymphoma kinase inhibitors Bulletin of the Korean Chemical Society. 36: 520-525. DOI: 10.1002/Bkcs.10097  0.368
2014 Lee HJ, Latif M, Choe H, Ali I, Lee HK, Yang EH, Yun JI, Chae CH, Jung JK, Kim HR, Lee CO, Park CH, Lee K. ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment. Archives of Pharmacal Research. 37: 1130-8. PMID 24446111 DOI: 10.1007/S12272-013-0323-Z  0.733
2014 Yun JI, Yang EH, Latif M, Lee HJ, Lee K, Yun CS, Park CH, Lee CO, Chae CH, Cho SY, Jung HJ, Kim P, Choi SU, Kim HR. Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities. Archives of Pharmacal Research. 37: 873-81. PMID 24129617 DOI: 10.1007/S12272-013-0247-7  0.689
2014 Latif M, Jung ME, Lee K, Choi G. Synthesis and biological evaluation of tetrapeptide ketones as reversible 20S proteasome inhibitors Bulletin of the Korean Chemical Society. 35: 3571-3575. DOI: 10.5012/Bkcs.2014.35.12.3571  0.381
2013 Park CH, Choe H, Jang IY, Kwon SY, Latif M, Lee HK, Lee HJ, Yang EH, Yun JI, Chae CH, Cho SY, Choi SU, Ha JD, Jung H, Kim HR, et al. Novel bis-ortho-alkoxy-para-piperazinesubstituted-2,4-dianilinopyrimidines (KRCA-0008) as potent and selective ALK inhibitors for anticancer treatment. Bioorganic & Medicinal Chemistry Letters. 23: 6192-6. PMID 24095090 DOI: 10.1016/J.Bmcl.2013.08.090  0.731
2013 Saeed A, Al-Masoudi NA, Latif M. Synthesis and antiviral activity of new substituted methyl [2-(arylmethylene-hydrazino)-4-oxo-thiazolidin-5-ylidene]acetates. Archiv Der Pharmazie. 346: 618-25. PMID 23828482 DOI: 10.1002/Ardp.201300057  0.343
2013 Latif M, Saeed A, Kim SH. Journey of the ALK-inhibitor CH5424802 to phase II clinical trial. Archives of Pharmacal Research. 36: 1051-4. PMID 23700294 DOI: 10.1007/S12272-013-0157-8  0.335
2013 Yang EH, Yun JI, Latif M, Lee HJ, Yun C, Lee K, Park CH, Cho SY, Jung HJ, Kim P, Ha JD, Kim HR. New Pyrimidine Derivatives possessing ALK Inhibitory Activities Bulletin of the Korean Chemical Society. 34: 3129-3132. DOI: 10.5012/Bkcs.2013.34.10.3129  0.696
2010 Saeed A, Khera RA, Abbas N, Latif M, Sajid I, Flörke U. Synthesis, characterization, crystal structures, and antibacterial activity of some new 1-(3,4,5-trimethoxybenzoyl)-3-aryl thioureas Turkish Journal of Chemistry. 34: 335-345. DOI: 10.3906/Kim-0810-44  0.356
Show low-probability matches.